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Abstract 
Background: Advance provision of misoprostol to women during antenatal care aims to achieve broader access to 
uterotonics for the prevention of postpartum hemorrhage. Studies of this community-based approach usually involve 
antenatal education as well as timely postpartum follow-up visits to confirm maternal and neonatal outcomes. The 
MamaMiso study in Mbale, Uganda sought to assess the feasibility of conducting follow-up visits in the postpartum 
period following advance provision of misoprostol for postpartum hemorrhage prevention. MamaMiso recruited 
women during antenatal care visits. Participants were asked to contact the research team within 48 h of giving birth 
so that postpartum follow-up visits could be carried out at their homes. Women’s baseline and delivery characteristics 
were collected and analyzed with respect to follow-up time (‘on time’ ≤ 7 days, ‘late’ > 7 days, and ‘lost to follow up’). 
Every woman who was followed up late due to a failure to report the delivery was asked for the underlying reasons 
for the delay. When attempts at following up participants were unsuccessful, a file note was generated explaining the 
details of the failure. We abstracted data and identified themes from these notes.
Results: Of 748 recruited women, 700 (94%) were successfully followed up during the study period, 465 (62%) within 
the first week postpartum. The median time to follow up was 4 days and was similar for women who delivered at 
home or in facilities and for women who had attended or unattended births. Women recruited at the urban hospital 
site (as opposed to rural health clinics) were more likely to be lost to follow up or followed up late. Of the women 
followed up late, 202 provided a reason. File notes explaining failed attempts at follow up were generated for 164 
participants. Several themes emerged from qualitative analysis of these notes including phone difficulties, inaccurate 
baseline information, misperceptions, postpartum travel, and the condition of the mother and neonate.
Conclusions: Keeping women connected to the health system in the postpartum period is feasible, though reach-
ing them within the first week of their delivery is challenging. Understanding characteristics of women who are 
harder to reach can help tailor follow-up efforts and elucidate possible biases in postpartum study data.
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Background
Misoprostol is a low-cost, effective [1–4], and safe [5] 
intervention for the prevention of postpartum hemor-
rhage (PPH); however its usefulness is dependent upon 
its availability at the place and time of delivery. An inte-
grative review of global implementation efforts suggests 
that self-administration of the medicine by women deliv-
ering at home is a way to achieve broader uterotonic 
coverage to prevent PPH [6]. To date, there are several 
published experiences with antenatal distribution of 
misoprostol to women for self-administration including 
efforts in Afghanistan [7], Nepal [8], Ghana [9], Liberia 
[10], Sudan [11], Nigeria [12], and Uganda [13].
Over two-thirds of the poorest women in sub-Saharan 
Africa give birth at home, and over half of their births are 
unattended [14]. Postpartum follow-up visits at home 
can help keep women connected to the health system. 
This strategy has been used in research to track the self-
administration of misoprostol in order to provide insight 
into best distribution strategies and resource utilization. 
Additionally, these visits can provide data on a range of 
delivery outcomes for women in the community; such 
data can be helpful in the evaluation of efforts to improve 
health outcomes for women after childbirth.
In Uganda, the MamaMiso study was a randomized, 
placebo-controlled trial of antenatal distribution of mis-
oprostol to women for self-administration to prevent 
postpartum hemorrhage [13]. One of the aims of the 
study was to assess the feasibility of conducting follow-up 
visits for data collection on maternal and neonatal out-
comes in the immediate postpartum period and to track 
the distributed medicines. This analysis presents quanti-
tative and qualitative findings on which women were suc-
cessfully followed up and the self-reported descriptions 
of challenges associated with keeping connected to the 
study team during the immediate postpartum period.
Methods
From May to October 2012, a study of self-administered 
misoprostol for PPH prophylaxis (MamaMiso) was 
implemented in Eastern Uganda enrolling 748 women. 
The main clinical findings are reported elsewhere [13].
Trained clinical staff recruited pregnant women into 
MamaMiso during antenatal care visits at four partici-
pating health facilities (one regional hospital and three 
health centers). The regional hospital was a tertiary facil-
ity located in the center of town, serving a population of 
about 4–5 million people from 14 districts and staffed by 
OBGYN specialists. The health centers were rural facili-
ties staffed primarily by clinical officers and midwives. 
Women were only recruited to the study if they lived 
within one of the pre-specified 200 villages near to the 
recruiting centers.
During antenatal care visits, women with estimated 
gestational ages 34  weeks or higher who did not plan 
to travel after their delivery were informed about the 
study aims and procedures (details reported elsewhere). 
Women who consented to be involved in the study were 
asked for contact information including up to two tel-
ephone numbers and detailed directions to their place 
of residence (including a sketched map when possible). 
Baseline demographic data and reproductive histories 
were collected as well as an assessment of hemoglobin 
(Hb) levels. Women were provided with a neck purse 
containing the study medication (either misopros-
tol or placebo), instructions for its proper use, and a 
phone number to call to report their delivery. Women 
were asked to report their deliveries immediately either 
directly to the study team or to their village health teams 
(VHT) who would subsequently notify the study team. 
VHTs are composed of community volunteers who pro-
vide health information and linkages to health services.
Women were informed that a postnatal follow-up visit 
would be conducted at home 3-5  days after delivery, a 
period selected both to capture the nadir of the hemo-
globin reading and to minimize poor recall of labor and 
delivery. In the three health centers, a VHT Coordina-
tor was present at enrollment and linked the partici-
pants to VHTs who assisted with delivery notification. 
To incentivize timely notification of deliveries, VHTs 
were informed that they would receive 10,000 Ugandan 
Shillings (~  4 USD) for the timely report of a delivery. 
The incentive was split between the women and VHT 
if both were involved in the delivery notification and a 
smaller incentive was provided for deliveries reported 
after 5 days. Efforts were made to follow up women, even 
beyond the target time period of 3–5 days postpartum in 
order to confirm the well-being of the mother and new-
born. Upon successful follow up, women were provided a 
small gift of soap.
While the study aimed for follow up between 3 and 
5  days, for the purposes of this data analysis a cut-off 
time of 7 days postpartum was used to make it compara-
ble to other studies and research protocols (UNICEF and 
WHO recommend neonatal home based care within the 
first week of life [15]). Women were considered “on-time” 
if follow up was achieved within 1  week of the delivery 
date, “late” if they were successfully followed up 8 days or 
more after the delivery, and “lost” if the study team was 
never able to conduct a full follow-up interview. Some 
women who were “lost” were contacted by phone, and 
limited information was gathered on them. Patient char-
acteristics and clinical outcomes were then analyzed by 
these ‘time to follow up’ categories.
Nearly all delivery notifications were received by 
the Research Fellow, mostly by phone. The Research 
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Fellow then coordinated follow up by assigning a study 
staff member (midwife or nurse) to locate the woman, 
typically by using a motorcycle taxi to drive to the par-
ticipant’s home. Follow up consisted of an in-person 
interview using a standardized case report form and 
the assessment of hemoglobin levels, using a  Hemocue® 
handheld device (Hemocue, Angelholm, Sweden). Infor-
mation regarding the details of the delivery, medications 
used, and health status of the mother and baby were col-
lected. Unused medicines or empty foil packs were also 
retrieved during the visit.
When follow-up difficulties arose early on, a system 
of keeping extensive file notes was put into place. Each 
woman who did not report her delivery on time was 
asked why, and when attempts by staff to follow up par-
ticipants were unsuccessful, the details were noted.
This analysis seeks to understand the challenges of 
community-based follow up in the context of a pla-
cebo-controlled randomized trial of antenatal distribu-
tion of misoprostol to women for self-administration 
to prevent postpartum hemorrhage. Bivariate analy-
ses of background and follow-up characteristics were 
conducted by follow-up time and multivariate logis-
tic regression was used to predict follow-up category. 
Data were abstracted from the file notes and reviewed 
for initial and emergent themes using a general induc-
tive approach. Themes were identified through an itera-
tive process, and data were independently coded by two 
researchers (LF and MB).
Results
Of the 748 women recruited, 700 women (93.6%) were 
successfully followed up. The median time to follow 
up was 4  days, ranging from 2 to 115  days postpartum. 
Nearly two-thirds (62.2%) of recruited women were fol-
lowed up within 1 week postpartum and almost one-third 
after that (31.4%) with 48 women (6.4%) lost to follow up.
Bivariate analyses of participant baseline character-
istics indicated that site of enrollment, age, and nul-
liparity were associated with follow-up time (Table  1). 
Multinomial regression revealed that only site of recruit-
ment was significantly associated with follow up when 
all baseline characteristics were entered into the model. 
Women recruited at the hospital were more likely to be 
followed up late (p = 0.002) and were more likely to be 
lost to follow up (p < 0.001) than participants enrolled at 
health centers. Eleven percent of women recruited from 
the hospital site were lost to follow up compared to 1–4% 
recruited from the three health centers. Furthermore, the 
median time to follow up for women enrolled at the hos-
pital was 7 days versus 4 days for the other recruitment 
locations (p < 0.001).
Details related to the participants’ delivery were recorded 
regardless of delivery location and timing of follow up 
(Table 2). The proportion of women delivering at home was 
similar among those followed up on time versus late. Simi-
larly, use of the study medication at the time of birth did 
not differ between these two groups. However, the propor-
tion of women with postpartum anemia (Hb < 9 g/dL) was 
Table 1 Baseline characteristics by follow up time N (%) or mean [SD]
In multinomial logit regression of all baseline characteristics, only place of enrollment retained significance at p < 0.05 level in the model
* Represents statistically significant difference at p < 0.05 level among the groups for log transformed age using one-way ANOVA
a Defined as within one week of birth
b Represents statistically significant difference among the groups using Chi square at 0.05 level
Baseline participant characteristics n = 748
On time follow  upa (n = 465) Late follow up (n = 235) Lost to follow up (n = 48)
Place of  enrollmentb
 Hospital 138 (29.7) 137 (58.3) 35 (72.9)
 Health centers 327 (70.3) 98 (41.7) 13 (27.0)
Mean age* (years) 27.0 [6.7] 25.4 [5.5] 24.08 [5.6]
Nulliparousb 86 (18.5) 60 (25.5) 18 (37.5)
Primary occupation
 Housewife 349 (75.1) 178 (75.7) 34 (70.8)
 Employed 99 (21.3) 54 (23.0) 12 (25.0)
 Unemployed/student 17 (3.7) 3 (1.3) 2 (4.2)
Level of education completed
 No education 33 (7.1) 15 (6.4) 3 (6.3)
 Primary 266 (57.2) 111 (47.2) 22 (45.8)
 Secondary or higher 166 (35.7) 108 (46.2) 23 (47.9)
Mean hemoglobin at recruitment (g/dL) 11.2 [1.4] 11.3 [1.4] 11.4 [1.5]
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significantly higher among those followed up on time as 
compared to those followed up late (p < 0.001). Addition-
ally, a larger portion of women followed up late reported a 
delivery complication when compared to those followed up 
on time, including neonatal death (4.3% vs. 2.6%, p = 0.254), 
consulting a healthcare provider in the postpartum period 
(3.8% vs. 2.6%, p = 0.357), being admitted to a health facil-
ity (2.6% vs. 1.5%, p  =  0.378), having a surgery (1.3% vs. 
0.2%, p = 0.113), having a blood transfusion (1.3% vs 0.2%, 
p = 0.113), or experiencing a postpartum infection of any 
type (6.8% vs 4.9%, p = 0.219) though these outcomes were 
rare and none of the differences were statistically significant.
Themes explaining late follow up
Of the 235 women who were followed up outside of the 
7-day timeframe, 195 (82.6%) either notified the study 
team of their delivery late, or not at all. In fact, for 21 
participants, follow up took place as a result of the pro-
active calculation of expected delivery date by the study 
team and subsequent phone calls or home visits to par-
ticipants. Of participants followed up late, 202 supplied a 
reason (or several) for their lack of timely notification in 
response to an open-ended question.
While the quantitative data elucidates which women 
were more difficult to follow up, the qualitative data 
reveals several themes about why some of these difficul-
ties arose. Five main themes emerged: phone difficul-
ties, inaccurate baseline information, misperceptions, 
travel in the postpartum period, and the condition of the 
mother and neonate. Table 3 contains illustrative quota-
tions related to each theme.
Phone difficulties
Most women (70.3%; n = 526) provided at least one phone 
number during recruitment, and 29.3% (n = 219) provided 
two phone numbers. However, among women who reported 
a reason for not notifying the study team of their delivery, 
the most common reasons were phone related (n  =  68) 
including a lack of airtime, lack of reception, and batteries 
dying. Additionally, some women (n = 31) reported losing 
the study phone number to call to report their deliveries and 
others (n = 18) reported that they attempted to reach the 
study team by phone but were unsuccessful.
Women explained that it was not enough to have access 
to a phone as there were also important conditions for its 
use. The absence of a husband was reported by 10 women 
as a factor contributing to failed delivery notification, 
either because he was the only person with a phone or 
because phone use in his absence was not permitted.
Inaccurate baseline information
At enrollment, estimated gestational age (GA) (based on 
last normal menstrual period and clinical assessment) was 
recorded and the expected date of delivery calculated for 
each study participant. Eighty-seven women passed their 
expected date of delivery by more than 2 weeks, suggest-
ing inaccuracies in the estimated GA at enrollment. This 
resulted in 22 additional home visits to women who were 
still pregnant, requiring an unplanned use of resources 
(motorcycle fare and staff time).
Poorly described or possibly false addresses were also 
evident in the study staff follow-up notes. The study con-
tact/address form asked for extensive information on how 
to reach the woman’s home. However, upon attempting 
follow up, staff reported 35 instances when this informa-
tion appeared to be fabricated, and the women were not 
known within the village that they had reported as their 
place of residence.
Misperceptions
Of the 202 women who failed to notify the study staff of 
their deliveries and provided a reason why, 49 stated that 
they “forgot” and an additional 41 women thought it was 
unnecessary to inform the study team of the birth. There 
Table 2 Delivery characteristics by follow up time N (%)
a Defined as a doctor, midwife, or trained nurse
b Statistically significant difference using Chi square test at 0.05 level
c Maternal complications include: postpartum infection, postpartum consultation with health professional, postpartum admission to a health facility, surgery, and 
transfusion
Delivery participant characteristics n = 700
On time follow up (n = 465) Late follow up (n = 235)
Home delivery 195 (41.9) 104 (44.3)
Used study medication 256 (55.1) 141 (60.0)
Skilled birth  attendanta 269 (57.8) 134 (57.0)
Postnatal anemia (Hb < 9 g/dL)b 52 (11.2) 9 (3.8)
Self-reported heavy bleeding by pictorial 33 (7.1) 14 (6.0)
Neonatal death 12 (2.6) 10 (4.3)
Maternal  complicationc 30 (6.5) 18 (7.7)
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were two women who attributed the failure to report their 
deliveries to “fear” because they had not fully complied 
with the study instructions. Additionally, one participant 
reported that her neighbors discouraged her from con-
tacting the study team due to suspicions of the research. 
The file notes from staff show that once again the role 
of husbands was important, because in seven cases hus-
bands either refused follow up in their absence (which 
delayed the process) or were uncooperative or openly 
hostile to the study team.
Travel/events
Of the 48 women lost to follow up, 26 traveled outside of 
the study area postnatally as reported by the woman her-
self or her family and neighbors. Additionally, among the 
195 women providing reasons for late delivery notifica-
tion, traveling or moving were mentioned by 40. Reasons 
for postpartum travel included relocating to a family 
members’ home, traveling due to the death of a loved 
one, or marital discord.
Condition of mother/neonate
Self-reported maternal and neonatal complications 
including admission to a hospital, surgery, blood transfu-
sion, infection, or retained placenta were rare among par-
ticipants (outcomes unknown for those lost to follow up). 
However, the qualitative reports of 14 women suggest 
that experiencing poor health in the postpartum period 
impacted delivery notification and thus timely follow up.
Discussion
In the MamaMiso study, follow up in the immediate post-
partum period was feasible and a high follow-up rate 
(93.6%) was achieved. A similarly high follow-up rate [8] 
Table 3 Illustrative quotations
Participant numbers and locations have been redacted from quotations. Quotations from women were typically provided in one of the three local languages (Ateso, 
Lugisu, Lugwere) and translated by study staff into English for recording. The English grammar of some quotations has been amended to facilitate comprehension
THEME: phone difficulties “My phone was faulty, the battery was spoiled so I was off air” (Quotation from woman)
“I delivered at home and did not report because I did not have the phone because my husband had gone for 
a safari and had not come back…” (Quotation from woman)
“My husband does not allow me to make phone calls.” (Quotation from woman)
“I left the book which had your telephone number in the hospital. I did not remember about the telephone 
number on the participant information sheet.” (Quotation from woman)
THEME: inaccurate baseline information “I followed up the participant at the given address but failed to get her because the villages given don’t exist.” 
(Quotation from study staff )
“The [name of contact person provided] had died some time back, [the neighbors] told me that they had 
never come across the name of the participant in their village.” (Quotation from study staff )
“I couldn’t locate [the participant] and none of the residents from the shops could either…the residents 
directed me to the local chairperson’s home who also didn’t know this participant.” (Quotation from study 
staff )
THEME: misperceptions “I thought [reporting my delivery] was not important since I was fine after delivery.” (Quotation from woman)
“I delivered and forgot to call until a nurse called me and asked if I had delivered.” (Quotation from woman)
“Participant followed up late because she feared calling us due to the fact that she swallowed only two 
tablets and missed one… She thought we would blame her for not swallowing the third tablet.” (Quotation 
from study staff )
“[The husband] answered the phone … He wondered whether it was necessary to follow [the wife] up… 
He said he will need us to follow her up in his presence… He also asked me why a man called to find out 
whether she had delivered.” (Quotation from study staff )
THEME: travel/events “On my third day after delivery I lost someone and travelled… for a burial. That’s why the MamaMiso staff 
were not able to find me.” (Quotation from woman)
“When my baby died, I lost my marriage, that’s why you were not able to get me at my home. I had come 
here to stay with my mother.” (Quotation from woman)
“When I reached the home, I did not get the participant because she had lost her one twin and they had 
taken the twin to another village for burial.” (Quotation from study staff )
“I was told by the neighbor that she left for their village… after delivery. She went with her mother because 
they had a misunderstanding with her husband.” (Quotation from study staff )
THEME: condition of mother/neonate “I was very sick and confused so I could not remember to report to you people that I had delivered.” (Quota-
tion from woman)
“After the death of the baby I was disturbed in the mind so I could not even remember to notify you that I 
had delivered.” (Quotation from woman)
“I called the participant today… she said she was operated on and the baby passed on…she went to a rela-
tives place for more support.” (Quotation from study staff )
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was achieved in the community misoprostol study in Nepal, 
though experiences in Nigeria and South Sudan reported 
rates much lower (84 and 76% respectively) [11, 12]. In this 
study, similar rates of follow up were achieved irrespec-
tive of place of the birth and the presence of a skilled birth 
attendant. This finding may suggest that even women who 
are disconnected from the health system at the time of 
delivery by giving birth at home and without a skilled atten-
dant are still amenable to postpartum follow up.
MamaMiso found that the main impediment to timely 
postpartum follow up was late delivery notification. 
A study of neonatal postpartum visits in Bangladesh 
reported the same issue [16]. This experience showed 
that it was particularly effective to involve both women 
and VHTs in delivery notification and, as necessary, to 
seek women proactively by calculating expected delivery 
dates and by scanning health center registries for births.
Enrollment location appeared closely related to the 
success of follow-up visits. The study team hypothesized 
that participants recruited from the hospital were more 
difficult to follow up for a variety of reasons. First, hospi-
tal enrollees were urban women with fewer community 
connections and no VHT and thus study staff could not 
benefit from the assistance of a network of close-knit 
neighbors when searching for a participant. Another 
hypothesis is that women enrolling at the hospital were 
from farther reaches of the district and more likely to give 
false addresses both to qualify for antenatal care at the 
hospital and to qualify for the study. Last, the study team 
felt that urban addresses were inherently more difficult to 
locate due to the density of the housing and the transi-
ence of the populations. This finding has implications in 
light of the increasing urbanization of world populations 
and while some studies assume urban women have better 
access to care, this experience implies that they may in 
fact be more isolated or difficult to reach.
Late follow up may have a number of effects on out-
come data integrity. The recall of delivery outcomes might 
be related to the timing of follow up, causing a different 
degree of accuracy between the ‘on time’ and ‘late’ follow-
up groups; self-reports of complications following deliv-
ery reflect a longer period of time when women were 
followed up late; and hemoglobin assessments for those 
followed up late are subject to the natural rebound in the 
postpartum period (Fig. 1). Our data do show higher rates 
of anemia detected among women followed up within 
7  days, despite no differences in use of study medicine, 
antenatal hemoglobin levels, or self-reported excessive 
bleeding. It is plausible that women who experienced the 
symptoms of postpartum anemia were compelled to con-
tact the study team at a higher rate than those without 
such symptoms or it is similarly plausible that late follow 
up missed measuring the nadir of hemoglobin levels, thus 
misclassifying women who would otherwise have been 
considered anemic. However early follow up may also 
have over identified anemia. Hemoglobin levels naturally 
rise postnatally due to the loss of the excess body fluid of 
pregnancy (diuresis). Future studies should consider fol-
low-up timing differences as areas for potential bias when 
interpreting postpartum findings.
The qualitative data shows that the postpartum period 
can be a tumultuous one characterized by health com-
plications, life events, and travel; therefore some loss 
to follow up must be anticipated. Some of the barriers 
encountered, like family deaths requiring travel, were 
inevitable but others can be addressed through improve-
ments in research design for example recruiting women 
from their homes instead of antenatal clinics. Addition-
ally, despite informed consent and enrollment, some 
women may not wish to be followed up. Their rights as 
participants must be respected.
A strength of this work is that few studies have such 
extensive qualitative details on the reasons for successes 
and failures of postnatal follow up. This analysis is limited 
by the non-systematic nature of the qualitative data and 
is therefore best used for hypothesis generating and to 
extract lessons learned. Furthermore, as these data were 
self-reported, interpretations of the data may be limited 
by the truthfulness of explanations provided.
Conclusions
The strategies employed and lessons learned from the 
experience of MamaMiso can be applicable to a wide 
range of studies seeking to collect data on maternal or 
neonatal outcomes at the community level.
Keeping women connected to the health system in 
the postpartum period is feasible. The MamaMiso study 
showed that women who delivered at home and with-
out a skilled birth attendant were equally likely to be fol-
lowed up on time as those with institutional and attended 
deliveries. Women who enrolled during antenatal care at 
an urban hospital were especially difficult to follow up 
on time. In their own words, women explain that phone 
difficulties, misperceptions, postpartum travel, and con-
dition of the mother or neonate also interfere with post-
partum visits. Some of these issues can be ameliorated, 
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though others are inevitable. Consideration of which 
groups of women are harder to reach in a timely matter 
is important when interpreting study findings based on 
postpartum assessments.
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